Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 264.85 M

Bio-Techne Corporation Operating Cash Flow is USD 264.85 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -13.70% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 306.88 M, a 12.12% change year over year.
  • Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 273.72 M, a -20.56% change year over year.
  • Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 344.57 M, a 25.33% change year over year.
  • Bio-Techne Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 274.94 M, a 27.07% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities